FDA approves Jardiance to treat type 2 diabetes
The FDA announced it has approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Jardiance is distributed by Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut. August 01, 2014